On March 28 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The Food and Drug Administration is making "technical amendments" to its regulations on prior notice for imported food, it said (here). Changes include replacing references to the legacy Automated Commercial System with references to ACE, correcting inaccurate number designations of headings in the regulations, and changing an office’s name. The final rule also removes an outdated provision that prior notices for certain refused imports be submitted via FDA’s system rather than ACE. The final rule takes effect March 30.

On March 27 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On March 24-25 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On March 23 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The Food and Drug Administration issued its weekly Enforcement Report for March 22 that lists the status of recalls and field corrections for food, drugs, biologics and devices (here). The report covers both domestic and foreign firms.

On March 22 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On March 21 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

Four former commissioners of the Food and Drug Administration warned Congress that allowing personal importation of drugs would lead to a surge in counterfeit and substandard pharmaceuticals, in a letter posted to the Duke University Margolis Center for Health Policy website on March 17 (here). There's some “renewed debate” on allowing personal importation as a means to reduce the cost of prescription medicines, but addressing the serious issue of access to affordable drugs will “not be such a straightforward task,” said the letter, signed by former commissioners Robert Califf, Margaret Hamburg, Mark McClellan and Andrew von Eschenbach.

On March 20 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of: